ebomi
Colour theme
Sign in
Insider · CIK 0001536368

Kunkel Lori Anne

CIK 0001536368 Name as filed on the most recent filing

Filed as Kunkel Lori Anne (8)

21 transaction lines · from 8 filings · filed 2017-08-23 to 2026-07-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-07-06 Enliven Therapeutics, Inc.
ELVN 		S, Open-market sale 5,889 disposed 50.84 299,421.49 Form 4, filing 0001536368-26-000007
2026-07-06 Enliven Therapeutics, Inc.
ELVN 		S, Open-market sale 4,111 disposed 49.98 205,481.76 Form 4, filing 0001536368-26-000007
2026-06-05 Enliven Therapeutics, Inc.
ELVN 		S, Open-market sale 7,779 disposed 34.28 266,659.45 Form 4, filing 0001536368-26-000004
2026-06-05 Enliven Therapeutics, Inc.
ELVN 		S, Open-market sale 1,867 disposed 35.36 66,012.08 Form 4, filing 0001536368-26-000004
2026-06-05 Enliven Therapeutics, Inc.
ELVN 		S, Open-market sale 354 disposed 35.82 12,679.82 Form 4, filing 0001536368-26-000004
2019-01-23 Curis Inc
CRIS 		S, Open-market sale 14,800 disposed 1.05 15,581.44 Form 4, filing 0001209191-19-005351
2018-10-01 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 4,500 disposed 170.20 765,881.10 Form 4, filing 0001567619-18-003657
2018-10-01 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 500 disposed 171.90 85,948.00 Form 4, filing 0001567619-18-003657
2018-06-15 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 5,601 disposed 177.12 992,058.64 Form 4, filing 0001140361-18-028996
2018-06-15 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 1,235 disposed 175.64 216,919.60 Form 4, filing 0001140361-18-028996
2018-06-15 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 4 disposed 177.79 711.16 Form 4, filing 0001140361-18-028996
2018-06-14 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 28,440 disposed 180.28 5,127,023.84 Form 4, filing 0001140361-18-028996
2018-06-14 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 2,411 disposed 181.48 437,544.18 Form 4, filing 0001140361-18-028996
2018-06-14 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 1,541 disposed 182.35 280,996.26 Form 4, filing 0001140361-18-028996
2018-04-20 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 4,000 disposed 132.81 531,238.80 Form 4, filing 0001140361-18-019388
2018-04-20 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 900 disposed 131.98 118,779.48 Form 4, filing 0001140361-18-019388
2018-04-20 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 100 disposed 133.60 13,360.00 Form 4, filing 0001140361-18-019388
2017-11-02 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 2,800 disposed 85.21 238,590.52 Form 4, filing 0001140361-17-041152
2017-11-02 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 1,800 disposed 84.15 151,468.92 Form 4, filing 0001140361-17-041152
2017-11-02 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 400 disposed 86.28 34,511.00 Form 4, filing 0001140361-17-041152
2017-08-22 Loxo Oncology, Inc.
LOXO 		S, Open-market sale 10,000 disposed 75.17 751,731.00 Form 4, filing 0001140361-17-033124

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 21
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Kunkel Lori Anne, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001536368

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.